
Keywords: ventricular assist device (VAD); continuous-flow device; pediatrics; mechanical circulatory support (MCS); pediatrics heart transplantation; ACT; activated clotting time; FDA; Food and Drug Administration; GLP; good laboratory practice; IDE; Investigation